Tell us the journey of Morepen Laboratories and its ongoing activities.
The company started as an Active Pharma Ingredients (API) player in 1984 and then moved up the value chain from simple semi – synthetic products to complex multi stage synthesis. Within 18 months of filing its Drug Master File (DMF) in September, 1997, we attained the title of being the second largest manufacturer of Loratadine in the world. Morepen became the youngest Indian company to win US FDA approval for its flagship product ‘Loratadine’, whose patent was to expire in 2002.
By year 1998, we had set up three state-of-the-art manufacturing plants at Parwanoo, Baddi & Masulkhana in Himachal Pradesh, for manufacture of API, OTC and formulation products namely, antibiotics, anti-prozoals, Proton pump inhibitors, anti-diarrhoeal, anti-inflammatory and antiallergic products etc with international standings.
The company has tied up with many multinational generic companies to market its products in the developed and regulated markets. We follow the concept of Green Chemistry by developing various chemo enzymatic methods for its new as well existing products including Atorvastatin, Rosuvastatin, Ursodiol and other top selling drugs.
Recently, the company's quarter performance reported a significant growth. What key factors have driven the growth?
Recently, we received US FDA approval for our manufacturing facilities at Baddi and Masulkhana, and it allowed us to begin exports of our bulk drug Montelukast Sodium to the US and other regulated markets of the world in. It resulted in our export sales in Q1’FY 2019-20 for Montelukast Sodium to rise by 210 percent and that of Atorvastatin Calcium by 57 percentvis-a-vis the corresponding quarter of the previous fiscal. In domestic market, Atorvastatin and Rosuvastatin registered maximum growth of about 262 per cent each during the same period.
Bu hikaye Express Pharma dergisinin November 01-15, 2019 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Express Pharma dergisinin November 01-15, 2019 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Giriş Yap
Achieving Aatmanirbharta In APIs Are We On The Right Track?
As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats
Yokogawa launches OpreX Data Model Broker
A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation
Understanding the nuances of generics injectables
At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial
Trending in nutraceuticals: Science meets sustainability
Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe
The growth of e-pharmacies in India
Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these
Xylitol and Maltitol: Low-calorie sugar alternatives
Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste
Single-use TC gaskets and their importance
Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.
It's important to enhance customer experience so that existing customers are more loyal
Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer experience, and how the right CRM solution can help companies to identify, address and manage customer expectations more effectively, in an interaction with Viveka Roychowdhury
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Arun Kedia, Managing Director,VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment
Ensuring pharma compliance with testo data loggers
Testo data loggers can be used to test the optimum conditions for specific products or surroundings